SCHOTT Pharma AG & Co. KGaA (BIT:1SXP)

Market Cap	2.26B
Revenue (ttm)	986.21M
Net Income (ttm)	146.45M
Shares Out	n/a
EPS (ttm)	0.97
PE Ratio	15.45
Forward PE	15.99
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	76
Open	n/a
Previous Close	16.28
Day's Range	n/a
52-Week Range	14.56 - 30.40
Beta	n/a
RSI	54.83
Earnings Date	Feb 11, 2026

About BIT:1SXP

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold application...

• Industry: Glass Containers
• Founded: 1884
• Employees: 4,811
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1SXP

Financial Performance

In 2025, BIT:1SXP's revenue was 986.21 million, an increase of 3.04% compared to the previous year's 957.09 million. Earnings were 146.45 million, a decrease of -2.16%.